Parry Samuel, Zhang Jian
Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Am J Obstet Gynecol. 2007 May;196(5):476.e1-6. doi: 10.1016/j.ajog.2007.02.019.
We studied the role of multidrug resistance proteins in regulating transplacental transmission of corticosteroids and protease inhibitors.
We performed quantitative polymerase chain reaction and FACS analyses to study MDR1 (encodes P-glycoprotein) and MRP-1 expression in extravillous (HTR-8/SVneo) and villous (BeWo) trophoblast cells treated with saquinavir, a multidrug resistance protein substrate. We measured H3-dexamethasone and H3-ritonavir transfer across confluent, syncytialized BeWo cells before and after treatment with agents that inhibit multidrug resistance proteins.
Compared with baseline expression, messenger RNA and protein levels were increased significantly in trophoblast cells after treatment with saquinavir. H3-dexamethasone and H3-ritonavir levels increased in BeWo cells after treatment with anti-P-glycoprotein antibodies or cyclosporine A. Transfer of H3-labeled drugs from the apical (eg, maternal) to basolateral (eg, fetal) side of the syncytialized BeWo cell monolayer was increased significantly when cells were pretreated with anti-P-glycoprotein antibodies.
Multidrug resistance proteins regulate drug levels in trophoblast cells and may mediate transmission of therapeutic agents across the placenta.
我们研究了多药耐药蛋白在调节皮质类固醇和蛋白酶抑制剂经胎盘转运中的作用。
我们进行了定量聚合酶链反应和流式细胞术分析,以研究多药耐药蛋白底物沙奎那韦处理后的绒毛外(HTR-8/SVneo)和绒毛(BeWo)滋养层细胞中MDR1(编码P-糖蛋白)和MRP-1的表达。我们在使用抑制多药耐药蛋白的药物处理前后,测量了H3-地塞米松和H3-利托那韦在汇合、融合的BeWo细胞中的转运情况。
与基线表达相比,沙奎那韦处理后的滋养层细胞中信使核糖核酸和蛋白质水平显著增加。用抗P-糖蛋白抗体或环孢素A处理后,BeWo细胞中的H3-地塞米松和H3-利托那韦水平升高。当用抗P-糖蛋白抗体预处理细胞时,H3标记药物从融合的BeWo细胞单层的顶端(如母体)向基底外侧(如胎儿)侧的转运显著增加。
多药耐药蛋白调节滋养层细胞中的药物水平,并可能介导治疗药物经胎盘转运。